Junshi Biosciences' Oncology Drug Toripalimab Obta...
Category : Approval/Launch 17 October 2024Overview Toripalimab is the first and only treatment for nasopharyngeal carcinoma approved in Ind...
Overview Toripalimab is the first and only treatment for nasopharyngeal carcinoma approved in Ind...
Overview MaaT Pharma, a clinical-stage biotechnology company, announced full recruitment of its p...
Overview SELLAS Life Sciences Group has received Rare Pediatric Disease Designation (RPDD) from t...
Bayer submits marketing authorization application to EMA for elinzanetant to treat moderate to sever...
Overview The UK’s world leading life sciences sector will receive a £279 million boos...